MedTrace Logo

Prevention of Arrhythmia Device Infection Trial (PADIT Pilot)

NCT01002911 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2013-05-16

No results posted yet for this study

Summary

The goal of the pilot study is to compare conventional antibiotic therapy to an aggressive antibiotic therapy plan for the prevention of arrhythmia device infection in high-risk patients undergoing arrhythmia device procedures. All antibiotics are approved for use and readily available.

Conditions

  • Arrythmias

Interventions

DRUG

Cefazolin, Bacitracin, Cefalexin

Single does of Cefazolin 1-2 g iv given over 60-120 minutes, 60-120 minutes prior to skin incision, Bacitracin wash, Cefalexin 250-500 mg TID

DRUG

Cefazolin

Cefazolin 1-2 g iv given over 60-120 minutes, 60-120 minutes prior to skin incision

Sponsors & Collaborators

  • Population Health Research Institute

    lead OTHER

Principal Investigators

  • Dr. Andrew Krahn · University of British Columbia

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2012-01-31
Completion
2012-01-31

Countries

  • Canada

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01002911 on ClinicalTrials.gov